tag:www.gov.uk,2005:/government/organisations/medicines-and-healthcare-products-regulatory-agencyMedicines and Healthcare products Regulatory Agency - Activity on 바카라 사이트HM 바카라 사이트2025-06-06T14:16:25Z/guidance/access-new-active-substance-nas-work-sharing-initiative#2025-06-06T14:16:25Z2025-06-06T14:16:25ZAccess, new active substance and biosimilar work sharing initiativesInformation on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products./government/news/mhra-launches-new-digital-hub-in-leeds-to-drive-innovation-and-regional-growth#2025-06-06T13:31:37Z2025-06-06T13:31:37ZMHRA launches new digital hub in Leeds to drive innovation and regional growthThe new hub will strengthen the MHRA바카라 사이트s work with regional partners and boost the UK바카라 사이트s digital health and life sciences sector./government/publications/orphan-registered-medicinal-products#2025-06-06T12:29:50Z2025-06-06T12:29:50ZDecision: Orphan registered medicinal productsA list of authorised orphan medicinal products registered by the UK licensing authority./drug-device-alerts/field-safety-notices-19-to-23-may-2025#2025-06-06T12:18:06Z2025-06-06T12:18:06ZField Safety Notices: 19 to 23 May 2025List of Field Safety Notices from 19 to 23 May 2025./government/publications/human-and-veterinary-medicines-register-of-licensed-wholesale-distribution-sites#2025-06-05T14:20:17Z2025-06-05T14:20:17ZDecision: Human and veterinary medicines: register of licensed wholesale distribution sitesDepartment of Health and Social Care and MHRA register of licensed wholesale distribution sites (human and veterinary)./government/publications/medicines-new-manufacturing-and-wholesale-dealer-licences#2025-06-05T14:16:21Z2025-06-05T14:16:21ZDecision: Medicines: new manufacturing and wholesale dealer licencesList of sites granted a manufacturer or wholesale dealer licence./government/publications/human-and-veterinary-medicines-register-of-licensed-manufacturing-sites#2025-06-05T14:10:18Z2025-06-05T14:10:18ZDecision: Human and veterinary medicines: register of licensed manufacturing sitesThe MHRA register of licensed manufacturing sites: manufacturer specials - human (MS) and manufacturer specials authorisation - veterinary (MANSA) only./government/publications/medicines-terminated-and-cancelled-manufacturing-and-wholesale-dealer-licences#2025-06-05T14:05:17Z2025-06-05T14:05:17ZNotice: Medicines: terminated and cancelled manufacturing and wholesale dealer licencesUK companies who have their licence to manufacture or wholesale medicines terminated and cancelled. /government/publications/register-of-brokers-authorised-to-deal-in-human-medicines#2025-06-05T14:02:35Z2025-06-05T14:02:35ZNotice: Register of brokers authorised to deal in human medicinesCurrent listing of UK brokers authorised to broker human medicines, including company name, registration and address./government/publications/human-medicines-register-of-electronic-export-certificates#2025-06-05T13:42:10Z2025-06-05T13:42:10ZDecision: Human medicines: register of electronic export certificatesDepartment of Health and Social Care and MHRA register of electronic export certificates (human)./government/news/helping-bring-phage-medicines-to-uk-patients-guidance-for-industry#2025-06-05T08:44:17Z2025-06-05T08:44:17ZHelping bring phage medicines to UK patients 바카라 사이트 guidance for industryBacteriophages 바카라 사이트 viruses that selectively fight bacteria 바카라 사이트 may offer new hope in fighting infections and tackling antimicrobial resistance./government/news/women-on-skinny-jabs-must-use-effective-contraception-mhra-urges-in-latest-guidance#2025-06-04T23:01:03Z2025-06-04T23:01:03ZWomen on 바카라 사이트skinny jabs바카라 사이트 must use effective contraception, MHRA urges in latest guidance Anyone who suspects that they바카라 사이트ve had an adverse reaction to their weight loss or diabetes medicine or suspects it is not a genuine product, should report it to the MHRA. /government/publications/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know#2025-06-04T23:01:03Z2025-06-04T23:01:03ZGuidance: GLP-1 medicines for weight loss and diabetes: what you need to knowGuidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes./government/publications/regulatory-considerations-for-therapeutic-use-of-bacteriophages-in-the-uk#2025-06-04T10:02:19Z2025-06-04T10:02:19ZGuidance: Regulatory considerations for therapeutic use of bacteriophages in the UKThis publication clarifies which regulatory guidelines should be followed, and which apply, in the development of phage therapeutic products./guidance/regulatoryconnect#2025-06-04T09:47:30Z2025-06-04T09:47:30ZRegulatoryConnectThe Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details./government/publications/disapplication-of-falsified-medicines-directive-safety-features-requirements-for-parallel-imports#2025-06-03T13:54:12Z2025-06-03T13:54:12ZGuidance: Disapplication of Falsified Medicines Directive Safety Features: Requirements for Parallel ImportsInformation relating to the disapplication of falsified medicines under UK Law./government/publications/uk-parallel-import-licences-following-agreement-of-the-windsor-framework#2025-06-03T13:52:44Z2025-06-03T13:52:44ZGuidance: UK parallel import licences following agreement of the Windsor FrameworkInformation relating to parallel imports and the implementation of the Windsor Framework./drug-device-alerts/field-safety-notices-26-to-30-may-2025#2025-06-03T09:26:52Z2025-06-03T09:26:52ZField Safety Notices: 26 to 30 May 2025List of Field Safety Notices from 26 to 30 May 2025./government/news/mhra-approves-aumolertinib-to-treat-non-small-cell-lung-cancer#2025-06-02T23:00:00Z2025-06-02T23:00:00ZMHRA approves aumolertinib to treat non-small cell lung cancerAs with all products, we will keep its safety under close review/drug-device-alerts/class-4-medicines-notification-zentiva-pharma-uk-limited-various-products-el-25-a-slash-24#2025-06-02T10:01:44Z2025-06-02T10:01:44ZClass 4 Medicines Notification, Zentiva Pharma UK Limited, Various Products, EL(25)A/24Zentiva Pharma UK Limited has informed the MHRA of an issue related to batches of various soluble or effervescent tablets.